The treatment for metastatic renal cell carcinoma / 中华泌尿外科杂志
Chinese Journal of Urology
; (12): 474-476, 2020.
Article
de Zh
| WPRIM
| ID: wpr-869674
Bibliothèque responsable:
WPRO
ABSTRACT
The prognosis of metastatic renal cell carcinoma is relatively poor. With the development of molecular biology, the treatment of metastatic renal cell carcinoma is undergoing a transformation from cytokine therapy to targeted molecular therapy or immunotherapy, and the prognosis has been improved. This study summarized and discussed the treatment progress of metastatic renal cell carcinoma.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Urology
Année:
2020
Type:
Article